Zhu C C, Wojcikiewicz R J
Department of Pharmacology, College of Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210-2339, USA.
Biochem J. 2000 Jun 15;348 Pt 3(Pt 3):551-6.
Down-regulation of the Ins(1,4,5)P(3) receptor is an adaptive response to the activation of certain phosphoinositidase C-linked cell-surface receptors. It is manifested as a profound decline in cellular Ins(1,4,5)P(3) receptor content, occurs with a half-time of 0.5-2 h and is due to accelerated proteolysis. It has been shown that this process is mediated by the ubiquitin/proteasome pathway and is therefore initiated by Ins(1,4,5)P(3) receptor ubiquitination. To investigate the role of ligand binding in Ins(1,4,5)P(3) receptor ubiquitination, we expressed 'exogenous' wild-type and ligand-binding-defective mutant type I Ins(1,4,5)P(3) receptors in human neuroblastoma SH-SY5Y cells, in which muscarinic receptor activation elicits Ins(1,4,5)P(3) receptor down-regulation. We found (1) that exogenous wild-type Ins(1,4,5)P(3) receptors are efficiently ubiquitinated in response to muscarinic receptor stimulation, (2) that exogenous ligand binding-defective mutant Ins(1,4,5)P(3) receptors are resistant to ubiquitination, (3) that this resistance is not caused by the removal of potential ubiquitin-conjugating sites in the mutated region, and (4) that in heterotetramers of exogenous mutant receptors and 'endogenous' receptors, only the latter are targeted for ubiquitination. These results indicate that the binding of Ins(1,4,5)P(3) directly stimulates ubiquitination of the Ins(1,4,5)P(3) receptor and that the targeting of Ins(1,4,5)P(3) receptors for ubiquitination is a highly specific process. We therefore propose that an Ins(1,4, 5)P(3)-binding-induced conformational change in the receptor exposes a degradation signal that leads to ubiquitination.
肌醇-1,4,5-三磷酸(Ins(1,4,5)P(3))受体的下调是对某些磷脂酰肌醇特异性磷脂酶C偶联的细胞表面受体激活的一种适应性反应。它表现为细胞内Ins(1,4,5)P(3)受体含量的显著下降,发生的半衰期为0.5 - 2小时,且是由于蛋白水解加速所致。已表明该过程由泛素/蛋白酶体途径介导,因此是由Ins(1,4,5)P(3)受体泛素化引发的。为了研究配体结合在Ins(1,4,5)P(3)受体泛素化中的作用,我们在人神经母细胞瘤SH - SY5Y细胞中表达了“外源性”野生型和配体结合缺陷型I型Ins(1,4,5)P(3)受体,在该细胞中,毒蕈碱受体激活会引发Ins(1,4,5)P(3)受体下调。我们发现:(1)外源性野生型Ins(1,4,5)P(3)受体在毒蕈碱受体刺激下能有效地被泛素化;(2)外源性配体结合缺陷型突变Ins(1,4,5)P(3)受体对泛素化具有抗性;(3)这种抗性不是由突变区域中潜在的泛素结合位点的去除引起的;(4)在外源性突变受体和“内源性”受体的异源四聚体中,只有后者被靶向进行泛素化。这些结果表明,Ins(1,4,5)P(3)的结合直接刺激了Ins(1,4,5)P(3)受体的泛素化,并且Ins(1,4,5)P(3)受体被靶向进行泛素化是一个高度特异性的过程。因此,我们提出Ins(1,4,5)P(3)结合诱导的受体构象变化暴露了一个导致泛素化的降解信号。